L. Stein-Gold, B. Elewski, Z. Draelos, and T. Lin, “Safety and Efficacy of a Fixed Combination Halobetasol Propionate 0.01%/Tazarotene 0.045% (HP/TAZ) Lotion in the Treatment of Females With Moderate-to-Severe Plaque Psoriasis”, J of Skin, vol. 4, no. 1, p. S9, Jan. 2020.